Indicated to the treatment of pediatric sufferers that have growth failure on account of an inadequate secretion of endogenous growth hormone (GH). GENOTROPIN is contraindicated in sufferers with a acknowledged hypersensitivity to somatropin or any of its excipients. Severe systemic hypersensitivity reactions together with anaphylactic reactions and angioedema have been https://nazimi432ukz9.verybigblog.com/profile